The RECOVER Long COVID study at Boston Medical Center seeks to understand, treat, and prevent the long-term effects of COVID-19. Part of nationwide effort, we are currently enrolling patients in a Boston-based study cohort to support research that will develop new approaches to diagnosis and treatment. Learn more about the RECOVER Long COVID Study.
"It’s important that we work to expand our knowledge about the long-term impacts of the COVID-19 virus in order to address — and help prevent — another public health crisis. This consortium will help us gather the data necessary to better understand the spectrum of how this virus presents in individuals, including among vulnerable populations that were hardest hit by COVID-19."
- Nahid Bhadelia, MD, MALD,
Infectious Disease Expert and Co-Principal Investigator of Boston Medical Center RECOVER study cohort
About the BMC RECOVER Study
The RECOVER study at Boston Medical Center seeks to understand, treat, and prevent the long-term effects of COVID-19. Our study is part of a national cohort funded by the National Institute for Health (NIH) with the goal of fully understanding the condition referred to as “post-acute sequelae of SARS-CoV-2” (PASC), or “long COVID.” The RECOVER (Research COVID to Enhance Recovery) study believes that:
Progress takes people like you
If you are currently or have been infected with COVID-19, we invite you to participate in this study to help scientists learn more about the effects of infection on long-term health. Our study team is committed to learning more, and your participation is crucial to helping scientist gain a deeper understanding of Long Covid.
Progress takes inclusion
We are currently enrolling patients from the inpatient and outpatient settings of Boston Medical Center, patients of the ReCOVer Long Covid Clinic, and patients from community health centers throughout the Boston area.
Progress takes coordinated action
Our study is part of a nationwide consortium of hospitals and institutions coming together to learn more about the long-term effects of COVID-19. Across Boston, we are one of the hospitals joining the network of hospitals funded by the National Institute of Health (NIH) to carry out this study.
What is Long COVID?
Given the number of patients who have been or will be infected with SARS-CoV-2, the public health impact of PASC could be very large. Despite recovery from initial infection, many patients continue to experience a number of symptoms — including fatigue, shortness of breath, brain fog, sleep disorders, fevers, gastrointestinal symptoms, abnormal blood clotting, loss of taste and/or smell, anxiety, and depression. These symptoms collectively are now referred to as a condition called post-acute sequelae of SARS-CoV-2” (PASC), or “long COVID.”
Even if someone did not experience symptoms during their initial infection, PASC is still relevant because a patient could still experience long-term effects after acute infection.
- BMC ReCOVer Long COVID clinic
- Community Health Centers throughout the Boston area
- Center for Emerging Infectious Diseases Policy and Research (CEID)
- Boston University General Clinical Research Unit (GCRU)
- Boston-wide partners:
- Mass General Brigham Hospital
- Tufts Medical Center
- Beth Israel Deaconess Medical Center
Please check back for the latest updates from our study team.
- Are you a member of the media or press? Please direct inquiries to the BMCRecover@bmc.org.
- For more information about partnering with us on this study or for further questions, please call 617.414.8282 or email us at BMCRecover@bmc.org
- To contact the ReCOVer Long COVID Clinic at BMC, please click here.